Related Experiment Videos

Murine macrophage interleukin-1 release by capsularlike serotype-specific polysaccharide antigens of Actinobacillus

T Takahashi1, T Nishihara, Y Ishihara

  • 1Department of Dental Research, National Institute of Health, Tokyo, Japan.

Infection and Immunity
|January 1, 1991
PubMed

Insights

Serotype-specific polysaccharide antigens from Actinobacillus actinomycetemcomitans stimulate interleukin-1 release in macrophages. Deacetylation enhanced this immune response, suggesting acetyl groups may inhibit antigen-macrophage interaction.

Area of Science:

  • Immunology
  • Microbiology
  • Biochemistry

Background:

  • Actinobacillus actinomycetemcomitans is associated with periodontal disease.
  • Polysaccharide antigens (SPAs) are key components of bacterial cell walls.
  • Interleukin-1 (IL-1) is a crucial cytokine in immune responses.

Purpose of the Study:

  • To investigate the immunomodulatory effects of Actinobacillus actinomycetemcomitans serotype-specific polysaccharide antigens (SPAs).
  • To determine the role of SPAs in inducing interleukin-1 (IL-1) release from macrophages.
  • To explore the influence of polysaccharide structure, specifically acetylation, on immune cell activation.

Main Methods:

  • Extraction and purification of SPAs from Actinobacillus actinomycetemcomitans serotypes a, b, and c using autoclaving and chromatographic techniques.
  • Assay of IL-1 release from P388D1 murine macrophages stimulated with SPAs.
  • Analysis of IL-1 activity using anti-murine IL-1 serum and concanavalin A.
  • Gel filtration chromatography (Sephacryl S-200) to determine the molecular weight of released IL-1.

Main Results:

  • Y4 SPA (serotype b) potently induced IL-1 release from P388D1 macrophages, with minimal inhibition by Polymyxin B.
  • IL-1 release was confirmed by its ability to stimulate thymocyte proliferation, which was suppressed by anti-IL-1 serum.
  • A peak corresponding to approximately 16.5 kDa was identified as IL-1.
  • SPAs from serotypes a and c showed lower IL-1 inducing capacity, which was enhanced upon deacetylation, indicating steric hindrance by acetyl groups.

Conclusions:

  • Actinobacillus actinomycetemcomitans SPAs, particularly serotype b, are potent inducers of macrophage-derived IL-1.
  • Deacetylation of serotype a and c SPAs significantly enhances their IL-1 releasing capability.
  • Acetylation of bacterial polysaccharide antigens may act as a mechanism to modulate or reduce host immune cell activation.

Related Concept Videos